Trial NCT02906332

View at ClinicalTrials.gov 
Org. Study IDs: Pro2016-0262

Last trial update was posted on 2023-08-22

MeSH Interventions

Dexamethasone Lenalidomide Pembrolizumab

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

FDA Hold Due to Updated Risks

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID